The report is a response to the challenge from Norwegian prime minister Erna Solberg. Many opportunities are available. Success can be achieved with commitment and right instruments.
The threat posed by antibiotic resistance cannot be eliminated, but steps can be taken to reduce its progress.
Decades of medical research and progress could be reversed by antibiotic resistance.
The ecosystem in water, soil and organisms is disrupted by the production and use of pharmaceuticals and their subsequent disposal.
Norway is among the countries with the lowest consumption of antibiotics for both humans and animals, and has little problem with antibiotic resistance today.
Bacteriophages have a number of applications in such areas as human and veterinary medicine, aquaculture, agriculture and food processing.
In 2018, ACD Pharmaceuticals introduced CUSTUS®yrs as the world’s first bacteriophage product for use in aquaculture.
The report is a response to the challenge from Norwegian prime minister Erna Solberg. Many opportunities are available. Success can be achieved with commitment and right instruments.
ACD Pharma and sister company STIM are building the world’s first bacteriophage factory approved for pharmaceutical production, located alongside the companies’ new head offices.